Format

Send to

Choose Destination
Eur J Drug Metab Pharmacokinet. 1993 Jan-Mar;18(1):97-100.

Sparse data analysis.

Author information

1
Pharmacy Department, University of Manchester, UK.

Abstract

In recent years there has been a growing interest in techniques capable of analyzing sparse data, particularly gathered during Phase III clinical trials, and there is now pressure on manufacturers to obtain more kinetic and dynamic information from Phase III studies. Techniques for the analysis of sparse data are reviewed drawing on a number of examples taken from pharmacokinetic and pharmacodynamic experiments.

PMID:
8335044
DOI:
10.1007/BF03220012
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center